Loading…

Securities analysts expect CJ CheilJedang's Q2 2026 bio segment to rebound on pricing recovery, offsetting weakness in food. The company plans to raise prices on 27 food products by about 8%.
The article reflects amino acid pricing recovery at a producer level, but it is primarily corporate earnings commentary with limited direct effect on feed commodity prices.
Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.